Some baseline clinical variables of the 2 groups were still borderline significant; thus, the differences between these 2 strategies could be minimized by these confounding effects.
← all excerpts
Clinical outcomes of bivalirudin versus heparin in atrial fibrillation patients undergoing percutaneous left atrial appendage occlusion.
1
—
—